Nuveen’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-36,459
Closed -$49.2K 3752
2026
Q1
$49.2K Hold
36,459
﹤0.01% 3206
2025
Q4
$94.8K Hold
36,459
﹤0.01% 3215
2025
Q3
$109K Hold
36,459
﹤0.01% 3219
2025
Q2
$147K Sell
36,459
-225,382
-86% -$832K ﹤0.01% 3216
2025
Q1
$34.1M Buy
261,841
+212,662
+432% +$1.01M 0.01% 800
2024
Q4
$304K Hold
49,179
﹤0.01% 3125
2024
Q3
$274K Hold
49,179
﹤0.01% 3163
2024
Q2
$367K Buy
49,179
+30,535
+164% +$188K ﹤0.01% 3091
2024
Q1
$108K Hold
18,644
﹤0.01% 3245
2023
Q4
$92.1K Hold
18,644
﹤0.01% 3289
2023
Q3
$95.5K Hold
18,644
﹤0.01% 3128
2023
Q2
$126K Buy
+18,644
New +$111K ﹤0.01% 3143

Other funds holding BTMD

Nuveen's BTMD Position: Q2 2026 in Review

Nuveen sold out of Biote Corp (BTMD) in Q2 2026, closing a stake of 36,459 shares — an estimated $49.2K sold.

Nuveen first reported a position in BTMD in Q2 2023 and held it in 12 quarters. The position peaked at $34.1M in Q1 2025. 71 funds tracked by Wall St. Rank hold BTMD as of Q2 2026.

  • Nuveen reported no remaining Biote Corp position as of Q2 2026 after selling out during the quarter.
  • Nuveen sold 36,459 Biote Corp shares in Q2 2026, an estimated $49.2K.
  • Nuveen first reported a position in Biote Corp in Q2 2023 and held it in 12 quarters.
  • Nuveen's Biote Corp position peaked at $34.1M in Q1 2025.
  • 71 funds tracked by Wall St. Rank held Biote Corp as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.